Cancer Summaries and Commentaries™: Recent Advances in the Treatment of Gynecological Cancers: What we Learned in Barcelona

Cancer Summaries and Commentaries™: Recent Advances in the Treatment of Gynecological Cancers: What we Learned in Barcelona is organized by Physicians' Education Resource, LLC (PER).

Release Date: November 27, 2019
Expiration Date: November 27, 2020

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
This online activity is designed to update physicians on data presented at the EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY Annual Meeting, held in September 2019 in Barcelona, Spain. Cancer Summaries and Commentaries™: Recent Advances in the Treatment of Gynecological Cancers: What we Learned in Barcelona online continuing medical education (CME) activity facilitates critical assessment and clinical integration of new evidence, when appropriate. The activity reviews 9 abstracts with some of the most compelling and clinically relevant gynecological (GYN) cancer presentations from the meeting. For each abstract, a short summary of key clinical data is accompanied by expert perspectives that provide insight into how clinicians can apply these findings to their clinical practice to improve patient care.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Outline methods that allow for optimized characterization of tumor biology among patients with gynecologic malignancies
• Explain the study design, rationale, and results of recent clinical trials evaluating novel strategies for the treatment of gynecologic malignancies
• Consider recent evidence in the context of evolving treatment paradigms in the field of gynecologic malignancies

Benefits of Participating:
• Hear from the experts about recent clinical trials in the field of GYN malignancies and their impact on clinical practice decisions
• Identify opportunities to implement emerging treatments for the management of endometrial, cervical, and ovarian cancer
• Explore the role of biomarkers in the treatment and management of GYN malignancies